FEATURED: TomoTherapy on ‘The Doctors’ TV Show
On Tuesday, December 8, 2009, TomoTherapy was featured on The Doctors, a TV show broadcast nationally in the U.S. The episode featured an explanation of our advanced radiation therapy technology, along with a breast cancer patient’s treatment experience and a doctor’s clinical perspective. Below are links to the segments.
The Treatment Process
Dawn, 42, was diagnosed with breast cancer in 2007. In this segment, she undergoes TomoTherapy treatment, a highly-targeted form of targeted radiation therapy. The segment follows Dawn to a typical treatment visit. At the office, Dr. Robert Zimmerman of Vantage Oncology - Santa Clarita in California also explains what a patient should expect when being treated and how this technology overcomes limitations of previous technologies used to treat breast and other forms of cancer.
See TomoTherapy on The Doctors, part 1
TomoTherapy®: An Explanation
This segment features Dr. Robert Zimmerman demonstrating the advantages of TomoTherapy technology in front of The Doctors studio audience. Cancer patient, Dawn, who was treated by Dr. Zimmermann for breast cancer tells of her experience and current progress in beating her disease.
See TomoTherapy on The Doctors, part 2
About TomoTherapy Incorporated
TomoTherapy Incorporated develops, markets and sells advanced radiation therapy solutions that can be used to treat a wide variety of cancers, from the most common to the most complex. The ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy’s suite of solutions include its flagship Hi·Art® treatment system, which has been used to deliver more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions; the TomoHD™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device; and the TomoMobile™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care. TomoTherapy’s stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
8 Dec 2009
| Investor Contact: Thomas E. Powell Chief Financial Officer 608.824.2800 tpowell@tomotherapy.com |
Media Contact: Kevin O’Malley Manager Corporate Communications 608.824.2800 komalley@tomotherapy.com |
